Cargando…
Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System
Retroviral protease inhibitors (PIs) are fundamental pillars in the treatment of HIV infection and acquired immunodeficiency syndrome (AIDS). Currently used PIs are designed against HIV-1, and their effect on HIV-2 is understudied. Using a modular HIV-2 protease cassette system, inhibition profiling...
Autores principales: | Mahdi, Mohamed, Szojka, Zsófia, Mótyán, János András, Tőzsér, József |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690855/ https://www.ncbi.nlm.nih.gov/pubmed/26633459 http://dx.doi.org/10.3390/v7122931 |
Ejemplares similares
-
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020) -
Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation
por: Szojka, Zsófia, et al.
Publicado: (2020) -
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022) -
Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases
por: Mótyán, János András, et al.
Publicado: (2020) -
Biochemical Characterization of Human Retroviral-Like Aspartic Protease 1 (ASPRV1)
por: Golda, Mária, et al.
Publicado: (2020)